Lymphoma Trial, Recruiting NCT05858424 Sponsor: Centre Leon Berard Condition: Lymphoma
Back to Lymphoma

Lymphoma Trial, Recruiting

NCT05858424
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who were between 15 and 25 years old when they were diagnosed with their condition
  • People who were previously treated at the Paediatric Hematology and Oncology Institute (IHOPe) and/or the Leon Berard cancer centre (CLB) in the AYA (Adolescents and Young Adults) Department
  • People who were treated for a solid tumour or a lymphoma (a type of blood cancer affecting the lymph system)
  • People whose cancer has fully responded to treatment and who have completed their end-of-treatment assessment
  • People who finished all their treatment, including any ongoing maintenance treatment, less than 2 months ago
  • People who are able to understand, read, and write in French
  • People who are enrolled in a health insurance plan
  • People who have been told about the study and have agreed to take part
  • For participants who are under 18 years old, a parent or legal guardian must also have given their consent

Who may not be able to join:

  • People who would not be able to attend follow-up appointments for the full 12 months of the study
  • People who are currently under a court or government-ordered restriction of liberty
  • People who have not agreed to participate, or who are not in a position to give informed consent

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Amandine BERTRAND, MD, Institut d'Hématologie et d'Oncologie Pédiatrique

Phone: 04787872606

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre Leon Berard
Registry
ClinicalTrials.gov
Start date
29 November 2022
Est. completion
1 July 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Health-related Quality of life - emotional functioning

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov